Pediatric 3tc published presentations and documents on DocSlides.
The IATT Optimal Pediatric ARV List. . Presented...
STRIIVING . Study. Design. Endpoints. Primary: pr...
vs. PI/r . monotherapy. Study PIVOT. Study MOBID...
ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N =...
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
Endpoints. Primary: proportion of patients with HI...
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Virologically. Suppressed. OLE Trial. LPV-RTV + ....
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
Case Report A states in the case of ectodermal dy...
Committee. Spring 2019. Project. Summary. Implemen...
(with perspectives from well-resourced and resour...
r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
Susan M. Graham . Assistant Professor, Medicine a...
Susan M. Graham . Assistant Professor, Medicine a...
Implementation Challenges. Annette H. Sohn, MD. T...
David Geffen School of Medicine. at University of...
Doravirine. /Lamivudine/TDF is Non-Inferior to . ...
2. Instituto Nacional de Ciencias Médicas y Nutr...
implementation of Dolutegravir. Meireles MV. , Pa...
Action. Improving Access to Optimized Treatment ....
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
David Geffen School of Medicine. at University of...
Dr. S . Ntshalintshali. Ngwelezana. hospital. N...
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Hall 11B, RAI Amsterdam. Uptake and Procurement of...
WHO HQ. The role of DTG based regimens in first- a...
nd. 90: Child Friendly Formulations . Victor Mu...
Dolutegravir based regimens in first- ad second-li...
Dovato. ). Last Updated: November 28, 2022. Prepar...
Copyright © 2024 DocSlides. All Rights Reserved